From October 1 to December 31, 2024, 54 Medicare Part B rebatable drugs will have an inflation-adjusted coinsurance rate equal to 20% of the inflation-adjusted payment amount.

Tirzepatide, known by its brand names Mounjaro® (for diabetes) and Zepbound® (for weight loss), is a GLP-1 drug over which Eli Lilly & Co. (“Lilly”) has a legal monopoly.

The company develops a name that’s catchy, distinctive, and easy to pronounce. In the U.S., that name is submitted to the FDA to ensure it’s not too similar to existing drug names.

Cough syrup, cigarettes and other easy-to-get recreational drugs are legal. July 5, 2013— -- intro: Americans are well-known for their illegal drugs: locking people up for them, fearing them ...